Alta Bates Summit Comprehensive Cancer Center Jobs
(Visit website)
Facility - Building Owners
Company Description:
For over twenty years, Aptium Oncology has been designing, building and managing cancer centers at leading hospitals with a steadfast vision: to transform cancer care environments by bringing core clinical services to one central place. The intent of this single place is to help patients achieve longer, better lives - and to improve cancer care one center at a time. At Aptium Oncology, we view each cancer center as an environment for achievement. A place where physicians can achieve professional fulfillment and breakthroughs in patient care. Where hospitals can achieve previously unattainable results for their business operations and communities. We are committed to creating an environment that fosters the professional and personal achievements of each person who crosses the threshold of a center. And by sharing these achievements across the network, the achievements of each center, each physician, and each hospital are further heightened. Patients are the beneficiaries of these achievements - every accomplishment brings us one step closer to our ultimate goal of longer, better lives for cancer patients and their families. Aptium Oncology is a wholly-owned subsidiary of AstraZeneca, an international bioscience company. AstraZeneca has spent more than ten years strengthening its capabilities and commitment to oncology care with the aim of becoming the leading anti-cancer company in the world. Aptium Oncology has found in AstraZeneca a parent company who can provide business systems, management expertise and capital resources essential to making its vision a reality: bringing patient-focused, state-of-the-art cancer care to new regions of the country. Aptium Oncology has developed an organization with proven expertise and invaluable data that enable it to thrive in a complicated and changing provider and payor marketplace. Aptium Oncology has consistently achieved strong growth while developing positive, long-term relationships with leading physicians, medical institutions, and payors. These strengths, enhanced by its relationship with AstraZeneca, will continue to fuel its goal of providing greater value and improved quality of life for cancer patients.
For over twenty years, Aptium Oncology has been designing, building and managing cancer centers at leading hospitals with a steadfast vision: to transform cancer care environments by bringing core clinical services to one central place. The intent of this single place is to help patients achieve longer, better lives - and to improve cancer care one center at a time. At Aptium Oncology, we view each cancer center as an environment for achievement. A place where physicians can achieve professional fulfillment and breakthroughs in patient care. Where hospitals can achieve previously unattainable results for their business operations and communities. We are committed to creating an environment that fosters the professional and personal achievements of each person who crosses the threshold of a center. And by sharing these achievements across the network, the achievements of each center, each physician, and each hospital are further heightened. Patients are the beneficiaries of these achievements - every accomplishment brings us one step closer to our ultimate goal of longer, better lives for cancer patients and their families. Aptium Oncology is a wholly-owned subsidiary of AstraZeneca, an international bioscience company. AstraZeneca has spent more than ten years strengthening its capabilities and commitment to oncology care with the aim of becoming the leading anti-cancer company in the world. Aptium Oncology has found in AstraZeneca a parent company who can provide business systems, management expertise and capital resources essential to making its vision a reality: bringing patient-focused, state-of-the-art cancer care to new regions of the country. Aptium Oncology has developed an organization with proven expertise and invaluable data that enable it to thrive in a complicated and changing provider and payor marketplace. Aptium Oncology has consistently achieved strong growth while developing positive, long-term relationships with leading physicians, medical institutions, and payors. These strengths, enhanced by its relationship with AstraZeneca, will continue to fuel its goal of providing greater value and improved quality of life for cancer patients.